Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Biomed Pharmacother. 2021 Dec;144:112335. doi: 10.1016/j.biopha.2021.112335. Epub 2021 Oct 23.
Cervical cancer is the fourth common gynecologic cancer and is considered as second leading cause of death among women. Various strategies are applied in treatment of cervical cancer including radiotherapy, chemotherapy and surgery. However, cervical cancer cells demonstrate aggressive behavior in advanced phases, requiring novel strategies in their elimination. On the other hand, SOX proteins are transcription factors capable of regulating different molecular pathways and their expression varies during embryogenesis, disease development and carcinogenesis. In the present review, our aim is to reveal role of SOX transcription factors in cervical cancer. SOX transcription factors play like a double-edged sword in cancer. For instance, SOX9 possesses both tumor-suppressor and tumor-promoting role in cervical cancer. Therefore, exact role of each SOX members in cervical cancer has been discussed to direct further experiments for revealing other functions. SOX proteins can regulate proliferation and metastasis of cervical cancer cells. Furthermore, response of cervical cancer cells to chemotherapy and radiotherapy is tightly regulated by SOX transcription factors. Different downstream targets of SOX proteins such as Wnt signaling, EMT and Hedgehog have been identified. Besides, upstream mediators such as microRNAs, lncRNAs and circRNAs can regulate SOX expression in cervical cancer. In addition to pre-clinical studies, role of SOX transcription factors as prognostic and diagnostic tools in cervical cancer has been shown.
宫颈癌是第四种常见的妇科癌症,也是女性死亡的第二大主要原因。治疗宫颈癌的方法有很多,包括放疗、化疗和手术。然而,宫颈癌细胞在晚期表现出侵袭性行为,需要新的策略来消除它们。另一方面,SOX 蛋白是转录因子,能够调节不同的分子途径,其表达在胚胎发生、疾病发展和癌变过程中发生变化。在本综述中,我们旨在揭示 SOX 转录因子在宫颈癌中的作用。SOX 转录因子在癌症中起着双刃剑的作用。例如,SOX9 在宫颈癌中既具有肿瘤抑制作用,也具有肿瘤促进作用。因此,我们讨论了每个 SOX 成员在宫颈癌中的确切作用,以指导进一步的实验,揭示其他功能。SOX 蛋白可以调节宫颈癌细胞的增殖和转移。此外,SOX 转录因子还可以调节宫颈癌对化疗和放疗的反应。已经鉴定出 SOX 蛋白的下游靶标,如 Wnt 信号通路、EMT 和 Hedgehog。此外,上游介质,如 microRNAs、lncRNAs 和 circRNAs,也可以调节宫颈癌中 SOX 的表达。除了临床前研究,SOX 转录因子在宫颈癌中的预后和诊断作用也得到了证实。
Int J Biol Macromol. 2021-6-1
Semin Cell Dev Biol. 2016-7-28
J Mammary Gland Biol Neoplasia. 2019-5-9
Semin Cancer Biol. 2020-12
Genes Dis. 2025-5-21
Naunyn Schmiedebergs Arch Pharmacol. 2025-5-20
Medicine (Baltimore). 2025-1-31